|
Volumn 7, Issue 6, 2004, Pages 582-590
|
Drug evaluation: E-5564.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG DERIVATIVE;
E5564;
ENDOTOXIN;
LIPID A;
ANIMAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG ANTAGONISM;
ENDOTOXEMIA;
HUMAN;
METABOLISM;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SEPSIS;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
ENDOTOXEMIA;
ENDOTOXINS;
HUMANS;
LIPID A;
RANDOMIZED CONTROLLED TRIALS;
SEPSIS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 4444283850
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (10)
|
References (53)
|